Pharmacotherapy of Sexual Offenders

Annals of Pharmacotherapy

Volumn 27, Issue 3, 1993, Pages 316-320

  Richer, Monique ^a   Crismon, M Lynn ^b  

^a UNIVERSITÉ LAVAL   (Canada)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN; CYPROTERONE ACETATE; FLUOXETINE; FLUTAMIDE; FOLLITROPIN; GONADORELIN; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; NAFARELIN; SEROTONIN AGONIST; TESTOSTERONE;

AGGRESSION; CASTRATION; HUMAN; LIBIDO; MEDICAL ETHICS; MEDICOLEGAL ASPECT; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; REVIEW; SEXUAL AROUSAL; SEXUAL CRIME; SEXUAL DEVIATION; TESTOSTERONE BLOOD LEVEL;

AGGRESSION; ANDROGEN ANTAGONISTS; CANADA; COMPARATIVE STUDY; ETHICS, MEDICAL; GONADORELIN; HUMAN; MALE; PARAPHILIAS; SEX OFFENSES;

EID: 0027499390     PISSN: 10600280     EISSN: 15426270     Source Type: Journal    
DOI: 10.1177/106002809302700314     Document Type: Article

References (29)

1. Diagnostic and statistical manual of mental disorders. Third edition, revised. Washington, DC: American Psychiatric Association, 1987: 279–90.
2. Berlin F. Issues in the exploration of biological factors contributing to the etiology of the “sex offender”, plus some ethical considerations. Ann N Y Acad Sci 1988; 528: 182–92.
3. Coulborn K Faller. Why sexual abuse? An exploration of the intergenerational hypothesis. Child Abuse Negl 1989; 13: 543–8.
4. Marshall WL. Intimacy, loneliness and sexual offenders. Behav Res Ther 1989; 27: 491–503.
5. Hall GC Nagayama. Sexual arousal and arousability in a sexual offender population. J Abn Psychol 1989; 2: 145–9.
6. Earls C. Aberrant sexual arousal in sexual offenders. Ann N Y Acad Sci 1988; 528: 41–8.
7. Hendricks SE Fitzpatrick DF Hartman K Quaife MA Stratbucker RA Graber B. Brain structure and function in sexual molesters of children and adolescents. J Clin Psychiatry 1988; 49: 108–12.
8. Langevin R Bain J Wortzman S Hucker S Dickey R Wright P. Sexual sadism: Brain, blood and behavior. Ann N Y Acad Sci 1988; 528: 163–71.
9. Raboch J Cerna H Zemek P. Sexual aggressivity and androgens. Br J Psychiatry 1987; 151: 398–400.
10. Griffin JE Wilson JD. Disease of the testes. In: Isselbach KJ Adams RD Braunwald E Petersdorf RG Wilson JD, eds. Harrison's principles of internal medicine. 9th ed. New York: McGraw-Hill, 1980: 1765–6.
11. Seim HC. Evaluation of serum testosterone and luteinizing hormone levels in sex offenders. Fam Pract Res J 1988; 7: 175–80.
12. Bradford JMW. Organic treatment for the male sexual offender. Ann N Y Acad Sci 1988; 528: 193–202.
13. Furby L Blackshaw L Weinrott MR. Sex offender recidivism: A review. Psychol Bull 1989; 105: 3–30.
14. Cooper AJ. Progestagens in the treatment of male sex offenders: A review. Can J Psychiatry 1986; 31: 73–79.
15. Bancroft J Tennent G Loucas K Cass J. The control of deviant sexual behaviour by drugs: Behavioural changes following estrogens and anti-androgens. Br J Psychiatry 1974; 125: 310–5.
16. Cooper AJ. A placebo-controlled trial of the antiandrogen cyproterone acetate in deviant hypersexuality. Compr Psychiatry 1981; 22: 458–65.
17. Gilby R Wolf L Goldberg B. Mentally retarded adolescent sex offenders. A survey and pilot study. Can J Psychiatry 1989; 34: 452–8.
18. Berlin FS Meinecke CF. Treatment of sex offenders with antiandrogenic medication: Conceptualization, review of treatment modalities, and preliminary findings. Am J Psychiatry 1981; 138: 601–7.
19. Langevin R Paitich D Hucker S Newman S Ramsay G Pope S et al., The effect of assertiveness training, Provera and sex of therapist in the treatment of genital exhibitionism. J Behav Ther Exp Psychiatry 1979; 10: 275–82.
20. Rousseau L Couture M Dupont A Labrie F Couture N. Effect of combined androgen blockade with an LHRH agonist and flutamide in one severe case of male exhibitionism. Can J Psychiatry 1990; 35: 338–41.
21. Product information. Synarel (nafarelin acetate). Palo Alto, CA: Syntex Laboratories, 1990.
22. Pearson HJ. Paraphilias, impulse control, and serotonin (letter). J Clin Psychopharmacol 1990; 10: 233.
23. Jenike MA. Obsessive-compulsive and related disorders: A hidden epidemic. N Engl J Med 1989; 321: 539–41.
24. Kafka MP. Successful antidepressant treatment of nonparaphilic sexual addictions and paraphilias in men. J Clin Psychiatry 1991; 52: 60–65.
25. Perilstein RD Lipper S Friedman LJ. Three cases of paraphilias responsive to fluoxetine treatment. J Clin Psychiatry 1991; 52: 169–70.
26. Kafka MP. Successful treatment of a paraphilic coercive disorder (a rapist) with fluoxetine hydrochloride. Br J Psychiatry 1991; 158: 844–7.
27. Bianchi MD. Fluoxetine treatment of exhibitionism (letter). Am J Psychiatry 1990; 147: 1089–90.
28. Berlin FS. The paraphilias and Depo-Provera: Some medical, ethical and legal considerations. Bull Am Acad Psychiatry Law 1989; 17: 233–9.
29. Mellela JT Travin S Cullen K. Legal and ethical issues in the use of antiandrogens in treating sex offenders. Bull Am Acad Psychiatry Law 1989; 17: 223–32.